Quick Answer
– What it is: A nationwide mass tort against Johnson & Johnson alleging its talc-based products caused ovarian cancer and mesothelioma in tens of thousands of users.
– Who qualifies: Women diagnosed with epithelial ovarian cancer, fallopian tube cancer, peritoneal cancer, or peritoneal mesothelioma after regular, long-term use of Johnson's Baby Powder or Shower to Shower.
– What it's worth: Individual awards in bellwether verdicts have ranged from $25 million to over $2 billion; negotiated settlement values in 2026 are expected to fall between $100,000 and $500,000 per qualifying claimant depending on diagnosis severity and duration of use.
Case Snapshot
| Detail | Information |
|---|---|
| Court | U.S. District Court, District of New Jersey (MDL); state courts active in NJ, CA, MO |
| MDL Number | MDL 2738 |
| Presiding Judge | Hon. Michael A. Shipp, U.S. District Court, D.N.J. |
| MDL Filed | October 4, 2016 |
| Bankruptcy Entity Created | LTL Management LLC (dissolved after Third Circuit rejection, 2023) |
| Current Status | Active litigation; global settlement negotiations ongoing in 2026 |
| Claimed Settlement Fund | J&J proposed $6.475 billion over 25 years (third bankruptcy plan, under court review) |
| Claims Filed | Approximately 62,000 active claims as of early 2026 |
Introduction
The latest news on the Johnson & Johnson talcum powder lawsuit confirms that this litigation, now spanning nearly a decade, has entered its most consequential phase in 2026. Two federal bankruptcy court rejections, a string of nine-figure jury verdicts, and approximately 62,000 pending claims have pushed J&J toward a structured global settlement that is now under active court review.
J&J discontinued talc-based Johnson's Baby Powder in the United States and Canada in May 2020, then globally in August 2023. That timeline is significant: it coincides with years of internal documents showing the company was aware of potential asbestos contamination in its talc supply.
The litigation is centered in MDL 2738 before Judge Michael A. Shipp in the District of New Jersey. That MDL consolidates federal claims for pretrial proceedings. State court dockets in Missouri, New Jersey, and California remain separately active.
For claimants and their families, the core question in 2026 is whether a global settlement will resolve the case or whether individual trials will resume. The answer depends on developments now unfolding at the district and appellate levels.
Latest News on Johnson & Johnson Talcum Powder Lawsuit
The most significant development in early 2026 is J&J's third attempt to resolve its talcum powder liability through a prepackaged bankruptcy settlement. The company's subsidiary, Red River Talc LLC, filed for Chapter 11 bankruptcy in September 2024, proposing a $6.475 billion fund paid over 25 years to resolve all current and future ovarian cancer claims.
That plan required approval from 75% of current claimants to proceed. Reports from court filings indicate J&J secured the threshold vote from current claimants, though the validity of that vote is being contested by several plaintiffs' firms on the steering committee.
As of early 2026, the U.S. Bankruptcy Court for the Southern District of Texas is reviewing the confirmation plan. Opposition from the plaintiffs' steering committee, which includes Beasley Allen and Motley Rice, centers on whether the fund is adequate given the volume and severity of claims.
Bold Callout: J&J's proposed $6.475 billion fund amounts to roughly $104,000 per current claimant at face value, before accounting for future claims, attorney fees, and administrative costs, a figure many plaintiffs' attorneys publicly characterize as insufficient.
*Attorneys handling these claims point to the gap between the proposed settlement per-claimant average and the verdicts secured in individual trials, arguing that the fund undervalues serious diagnoses like Stage III and Stage IV ovarian cancer.*
Talcum Powder Lawsuit Update 2026
The talcum powder lawsuit in 2026 is operating on two parallel tracks: the bankruptcy confirmation proceeding in Texas, and live MDL activity in New Jersey for claimants who opted out or whose claims fall outside the bankruptcy plan's scope.
Judge Shipp in MDL 2738 has maintained jurisdiction over non-bankruptcy claims. Bellwether trial scheduling remains a tool of pressure in settlement negotiations. The MDL currently lists approximately 62,000 active federal claims, with state court claims adding several thousand more.
J&J's position is that the $6.475 billion fund provides fair value. Plaintiffs' leadership disputes that math, particularly for claimants with mesothelioma, whose claims carry distinct causation theories and higher potential verdicts.
| Track | Court | Status |
|---|---|---|
| Bankruptcy Settlement Plan | S.D. Texas Bankruptcy Court | Under confirmation review, 2026 |
| Federal MDL Claims | D.N.J., Judge Michael A. Shipp | Active; bellwether scheduling maintained |
| State Court (Missouri) | St. Louis City Circuit Court | Active; trial-ready cases advancing |
| State Court (New Jersey) | Atlantic County Superior Court | Active; coordinated with MDL |
| State Court (California) | Los Angeles County Superior Court | Active; independent coordination |
*Attorneys handling these claims point to the state court track as a meaningful alternative for claimants whose claims may not be covered by the bankruptcy plan.*
What Is the Latest on the Talcum Powder Lawsuit
The latest courtroom activity confirms that J&J has not yet resolved this litigation, despite more than seven years of sustained legal pressure. The third bankruptcy filing by subsidiary Red River Talc LLC represents J&J's most serious effort to cap its total exposure at a defined dollar figure.
Key current developments as reported from court filings:
- January 2026: Bankruptcy court in Texas began formal confirmation hearings on the $6.475 billion plan
- February 2026: Plaintiffs' steering committee filed opposition briefs challenging the adequacy of the fund and the validity of the claimant vote
- March 2026: Mediation sessions between J&J and plaintiffs' leadership resumed under court-appointed mediator oversight
- Ongoing: MDL 2738 before Judge Shipp remains active for non-settling claimants
The core legal question now before the bankruptcy court is whether a non-debtor, meaning Johnson & Johnson itself as the solvent parent company, can use a subsidiary's bankruptcy to achieve a global release of claims against it.
*Attorneys handling these claims note that if the bankruptcy court approves the plan, claimants who voted "yes" will receive settlement payments, while those who opted out retain the right to pursue individual litigation.*
Bold Callout: The Third Circuit has already rejected two prior J&J bankruptcy strategies in 2021 and 2023, establishing that a financially healthy company cannot use Chapter 11 as a shield against mass tort liability. Whether the Texas court reaches the same conclusion is the defining question of 2026.
J&J Bankruptcy Talcum Powder Strategy Explained
J&J's bankruptcy strategy is known in legal circles as the "Texas Two-Step." It involves a legal maneuver permitted under Texas divisional merger law, where a solvent company splits itself into two entities, assigns all tort liability to one entity, then places that liability-holding entity into bankruptcy.
J&J executed this in October 2021, creating LTL Management LLC to hold the talcum powder liability. LTL filed for Chapter 11 bankruptcy immediately. The strategy was designed to halt individual trials and funnel all claims into a single bankruptcy proceeding.
The strategy failed twice:
| Attempt | Entity | Court | Outcome |
|---|---|---|---|
| First (Oct. 2021) | LTL Management LLC | D.N.J. Bankruptcy | Dismissed by Third Circuit, Jan. 2023 |
| Second (Apr. 2023) | LTL Management LLC (refiled) | D.N.J. Bankruptcy | Dismissed by Bankruptcy Court, July 2023 |
| Third (Sept. 2024) | Red River Talc LLC | S.D. Texas Bankruptcy | Under review, 2026 |
The Third Circuit's January 2023 ruling was categorical: a company must be in genuine financial distress to file for bankruptcy protection. LTL, funded by J&J guarantees, was not financially distressed.
*Attorneys handling these claims note that J&J's third attempt, filed in a different jurisdiction, reflects a deliberate forum selection strategy, given that the Southern District of Texas has historically been more receptive to mass tort bankruptcy reorganization plans.*
Johnson and Johnson Talcum Powder Lawsuit Update 2024
The year 2024 marked J&J's pivot from litigation defense to structured settlement strategy. After the second LTL bankruptcy dismissal in July 2023, J&J created Red River Talc LLC and filed its third bankruptcy in September 2024.
The company simultaneously launched an aggressive claimant outreach campaign, seeking the 75% supermajority vote required to confirm the plan under the "pre-packaged" bankruptcy model. J&J reported achieving that threshold, but plaintiffs' attorneys representing tens of thousands of claimants disputed the vote's validity.
In late 2024, several bellwether trials that had been stayed during bankruptcy proceedings were preparing to resume in state courts. Missouri and New Jersey state court judges signaled they would not delay further absent a confirmed federal plan.
*Attorneys handling these claims in state courts noted that J&J's failure to reach a confirmed settlement in 2024 preserved individual trial rights for claimants who rejected or were excluded from the bankruptcy plan.*
Bold Callout: A $45 million verdict against J&J in a New Jersey state court case involving a mesothelioma claimant was affirmed in 2024, reinforcing the strength of individual claims outside the bankruptcy track.
Johnson and Johnson Talcum Powder Lawsuit Update 2023
The year 2023 was defined by two decisive judicial rulings against J&J's bankruptcy strategy. In January 2023, the U.S. Court of Appeals for the Third Circuit ruled that LTL Management LLC had no right to remain in bankruptcy because it was not in genuine financial distress.
J&J refiled LTL's bankruptcy in April 2023, proposing an $8.9 billion settlement fund. That plan was dismissed by the bankruptcy court itself in July 2023, finding the refiling was an improper litigation tactic.
Those two dismissals returned approximately 40,000 federal claims to MDL 2738 before Judge Shipp. State court dockets, which had been informally stayed during the bankruptcy proceedings, began scheduling trial dates again.
*Attorneys handling these claims viewed the 2023 dismissals as a litigation inflection point, restoring the individual trial rights that the bankruptcy strategy had sought to extinguish.*
Bold Callout: The Third Circuit's January 2023 ruling is now cited in other mass tort bankruptcy disputes nationwide as precedent limiting the "Texas Two-Step" strategy.
Johnson and Johnson Talcum Powder Lawsuit Update 2022
The year 2022 was largely consumed by the LTL Management bankruptcy proceedings in the District of New Jersey and the appellate briefing that would eventually produce the Third Circuit's January 2023 ruling.
During 2022, tens of thousands of individual federal talcum powder cases were effectively frozen under the automatic stay imposed by LTL's bankruptcy filing. MDL 2738 activity before Judge Shipp slowed considerably, with pretrial proceedings paused.
State court judges in Missouri pushed back more aggressively. Several St. Louis circuit court cases were not stayed because state courts are not bound by automatic stays in federal bankruptcy proceedings for non-bankrupt defendants.
*Attorneys handling state court claims used 2022 to advance discovery and trial preparation in jurisdictions not affected by the federal bankruptcy stay.*
Bold Callout: At least three Missouri state court verdicts totaling more than $2.1 billion against J&J were being appealed or retried during 2022, providing ongoing trial leverage for the plaintiffs' coalition.
Litigation Watch: J&J's bankruptcy strategy, attempted three times between 2021 and 2024, has so far failed to achieve a judicially confirmed global resolution, keeping approximately 62,000 federal claims and thousands of state court claims in active litigation status as of 2026.
Johnson and Johnson Talcum Powder Lawsuit Update 2021
The year 2021 marked a turning point in the litigation's structure. J&J announced in May 2020 that it would discontinue talc-based Baby Powder in the U.S. and Canada. By mid-2021, the company was developing the Texas Two-Step bankruptcy strategy.
In August 2021, internal J&J documents obtained through litigation were unsealed, showing company scientists had identified asbestos fibers in talc samples dating back to the 1970s. Those documents strengthened causation arguments across thousands of pending claims.
J&J executed the LTL Management LLC split and bankruptcy filing in October 2021, immediately halting most federal litigation activity. The automatic stay applied to all claims against LTL as the designated liability entity.
*Attorneys handling these claims in 2021 pivoted to appellate strategy, challenging the bankruptcy's legitimacy, which ultimately produced the Third Circuit's landmark 2023 rejection.*
Bold Callout: As of the 2021 LTL filing, J&J faced approximately 38,000 pending talcum powder lawsuits, a number that has grown to roughly 62,000 total claims by early 2026.
Who Qualifies for the Talcum Powder Lawsuit
Qualifying for a talcum powder lawsuit claim requires meeting specific medical and product use criteria. Courts and plaintiffs' attorneys apply consistent eligibility standards across both the MDL and state court tracks.
Primary eligibility criteria:
- Diagnosis of epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, or peritoneal mesothelioma
- Regular, long-term use of Johnson's Baby Powder, Shower to Shower, or other J&J talc-based products applied to the genital area
- Product use that predates the 2020 U.S. discontinuation
- Diagnosis occurring after a documented period of product use (most successful claims involve use of 10 or more years)
Who may not qualify:
- Individuals diagnosed with other cancer types not linked to talc exposure
- Those who used talc products only occasionally or briefly
- Claims where the only exposure was post-2020 reformulated (cornstarch-based) products
- Claims where the statute of limitations has expired without a tolling agreement in place
*Attorneys handling these claims note that family members of deceased claimants may file wrongful death or survival claims, subject to individual state probate and tort rules.*
| Diagnosis Type | Covered by MDL 2738 | Covered by Bankruptcy Plan |
|---|---|---|
| Epithelial Ovarian Cancer | Yes | Yes (primary coverage) |
| Fallopian Tube Cancer | Yes | Yes |
| Primary Peritoneal Cancer | Yes | Yes |
| Peritoneal Mesothelioma | Yes | Disputed; separate track |
| Lung Mesothelioma (asbestos) | Separate litigation | Not covered |
Talcum Powder Ovarian Cancer Lawsuit
The ovarian cancer claims form the numerical core of this litigation, representing the majority of the approximately 62,000 active federal claims in MDL 2738. The scientific theory linking genital talc use to ovarian cancer is based on two pathways: direct migration of talc particles through the reproductive tract, and inflammatory response triggered by talc particle lodgment in ovarian tissue.
Plaintiffs' experts have introduced epidemiological studies showing women who used talc products for genital hygiene had a 20% to 40% elevated risk of ovarian cancer compared to non-users. J&J has contested the scientific validity of these studies throughout the litigation.
Key diagnostic categories in ovarian cancer claims:
- Stage I and II diagnoses: Lower severity, typically attract lower settlement values
- Stage III and IV diagnoses: Higher severity, typically attract higher settlement values and stronger punitive damages arguments
- Deceased claimants: Wrongful death claims filed by estate representatives
*Attorneys handling ovarian cancer claims note that the strength of the causal link between duration of use and cancer development is central to both settlement valuation and trial strategy.*
Bold Callout: A $2.12 billion jury verdict in a Missouri case involving 22 plaintiffs with ovarian cancer remains one of the largest product liability verdicts in U.S. history, though it was later reversed on jurisdictional grounds, not on the merits of the cancer causation evidence.
Mesothelioma Talcum Powder Lawsuit
Mesothelioma claims within the talcum powder litigation follow a distinct causation theory: that J&J's talc supply was contaminated with asbestos, a known carcinogen, and that inhalation or ingestion of that contaminated talc caused peritoneal mesothelioma.
These claims are legally and scientifically separate from the ovarian cancer claims. Mesothelioma claimants must establish asbestos contamination in the specific product they used, a requirement supported by testing of retained product samples or lot number evidence.
Mesothelioma claims are not cleanly covered by J&J's current $6.475 billion bankruptcy plan. Red River Talc LLC's proposed fund primarily addresses ovarian cancer claims. Mesothelioma claimants and their attorneys have contested the adequacy of the plan for this category specifically.
*Attorneys handling mesothelioma claims note that these cases often proceed on a faster trial track given the severity and prognosis of the disease, and that individual verdicts in mesothelioma cases have historically been higher than ovarian cancer cases on a per-claimant basis.*
| Claim Type | Causation Theory | Covered by Bankruptcy Plan | Typical Verdict Range |
|---|---|---|---|
| Ovarian Cancer | Talc particle migration | Yes (primary) | $500K to $50M+ |
| Peritoneal Mesothelioma | Asbestos contamination | Disputed | $5M to $50M+ |
Bold Callout: The FDA confirmed in 2019 that it found chrysotile asbestos in Johnson's Baby Powder samples, a finding J&J disputed but which significantly accelerated mesothelioma claim filings.
Litigation Watch: The scientific distinction between ovarian cancer claims and mesothelioma claims within MDL 2738 directly affects both settlement valuation and trial strategy, with mesothelioma claimants facing separate and contested coverage under J&J's current bankruptcy plan.
Talcum Powder Lawsuit Settlement Amount 2026
Settlement amounts in 2026 depend on which resolution track a claimant is on. The bankruptcy plan proposes a defined fund. Individual trial verdicts, by contrast, have reached amounts the fund cannot match on a per-claimant basis.
Current settlement value framework:
| Claimant Category | Expected Range Under Bankruptcy Plan | Individual Trial Verdict Range (historical) |
|---|---|---|
| Stage I-II Ovarian Cancer | $50,000 to $150,000 estimated | $500,000 to $5 million |
| Stage III-IV Ovarian Cancer | $150,000 to $500,000 estimated | $5 million to $50 million+ |
| Peritoneal Mesothelioma | Not fully addressed in current plan | $10 million to $50 million+ |
| Wrongful Death (deceased claimant) | Varies by state; plan addresses | $1 million to $20 million+ |
These are estimated ranges based on the proposed fund size divided across filed claims, attorney fee deductions (typically 33% to 40%), and severity tiers that plaintiffs' leadership is negotiating.
*Attorneys handling these claims emphasize that individual settlement amounts are not yet finalized because the bankruptcy plan confirmation is still pending, and that claimants who opt out retain the right to pursue independent trial verdicts.*
Bold Callout: If the $6.475 billion fund is confirmed and all current claims participate, the average gross payment per claimant is approximately $104,500 before fees and costs, though severity-based tiers would create significant variation above and below that figure.
Johnson & Johnson Talcum Powder Lawsuit Updates on the MDL
MDL 2738 in the District of New Jersey before Judge Michael A. Shipp remains the central federal coordination mechanism for talcum powder claims that fall outside the bankruptcy plan. MDLs consolidate pretrial proceedings, including discovery and motion practice, without merging claims for trial.
Judge Shipp has maintained the MDL's administrative infrastructure even during the bankruptcy periods, allowing it to resume full activity quickly after the 2023 bankruptcy dismissals. Expert discovery and causation briefing continued on a modified schedule.
The MDL's plaintiffs' steering committee, composed of firms including Beasley Allen, Motley Rice, and Levin Papantonio, has maintained coordinated litigation strategy across federal and state tracks. Their collective leverage in settlement negotiations derives from the volume of cases they control and their demonstrated willingness to take cases to trial.
*Attorneys handling MDL claims note that the bellwether trial process, where representative cases go to trial to inform settlement values, remains a key strategic tool even when a global resolution is under negotiation.*
MDL 2738 Fast Facts:
- Filed: October 4, 2016
- District: U.S. District Court, D.N.J., Trenton Division
- Presiding Judge: Hon. Michael A. Shipp
- Active federal claims: approximately 62,000 as of early 2026
- Plaintiffs' Steering Committee chair: Public record firms include Beasley Allen, Motley Rice, Levin Papantonio
How to File a Talcum Powder Lawsuit Claim
Filing a talcum powder lawsuit claim in 2026 involves a specific sequence of steps, and timing matters because statutes of limitations vary by state.
Step-by-step process:
- Confirm medical eligibility: Obtain medical records documenting your ovarian cancer or mesothelioma diagnosis, including pathology reports and treatment history.
- Document product use: Gather any evidence of Johnson's Baby Powder or Shower to Shower use, including purchase records, photographs, or witness statements.
- Consult a mass tort attorney: Attorneys who handle talcum powder claims work on contingency, meaning no fee unless you recover. The consultation is free.
- Sign a retainer and complete a fact sheet: In the MDL context, each claimant completes a Plaintiff Fact Sheet (PFS), a standardized document required by the court.
- The attorney files your claim: Depending on your state and the status of the bankruptcy plan, claims are filed in federal MDL court, state court, or registered as part of the bankruptcy settlement process.
- Await resolution: If the bankruptcy plan is confirmed, you receive notice of your allocation. If you opt out or the plan fails, your case proceeds to the MDL or state court track.
*Attorneys handling these claims note that claimants who have already been approached by J&J or its representatives about direct settlement should consult independent counsel before accepting any offer.*
Bold Callout: Most mass tort attorneys handling J&J talcum powder claims work on a 33% contingency fee for pre-trial settlements and up to 40% if the case proceeds to trial.
Talcum Powder Lawsuit Statute of Limitations
The statute of limitations is the legal deadline by which a lawsuit must be filed. In talcum powder cases, the clock does not necessarily start on the date of diagnosis. Most states apply the "discovery rule," which starts the limitations period when the claimant knew or reasonably should have known that their injury was caused by the product.
Statute of limitations by state (selected):
| State | Statute of Limitations (Personal Injury) | Discovery Rule Applied? |
|---|---|---|
| New Jersey | 2 years | Yes |
| California | 2 years | Yes |
| Missouri | 5 years | Yes |
| Texas | 2 years | Yes |
| New York | 3 years | Yes |
| Florida | 2 years (reduced from 4 in 2023) | Yes |
| Illinois | 2 years | Yes |
| Pennsylvania | 2 years | Yes |
The discovery rule is critical in talcum powder cases because many claimants did not connect their cancer diagnosis to talc use until news coverage of the lawsuit became widespread, particularly after 2016.
*Attorneys handling late-filing claims frequently rely on tolling arguments based on fraudulent concealment, arguing that J&J's failure to disclose internal asbestos testing data delayed claimants' ability to discover the causal connection.*
Bold Callout: Claimants who missed their state deadline may still qualify if their attorney can establish fraudulent concealment tolling based on J&J's internal document suppression.
Litigation Watch: The statute of limitations and the discovery rule together determine whether late-filing claimants can still bring claims in 2026, and the strength of fraudulent concealment arguments remains a live legal issue in multiple state court jurisdictions.
Update on J&J Talcum Powder Lawsuit: What Comes Next
The trajectory of this litigation in 2026 leads to one of three probable outcomes. Each has direct consequences for the approximately 62,000 current federal claimants and the thousands more in state courts.
Outcome 1: Bankruptcy Plan Confirmed
The Texas bankruptcy court approves Red River Talc LLC's $6.475 billion plan. Claimants who voted "yes" receive allocation notices and begin receiving payments on a schedule running up to 25 years. Claimants who opted out retain trial rights in MDL 2738 and state courts.
Outcome 2: Bankruptcy Plan Rejected
The court rejects the plan, following the Third Circuit's logic from 2023. All claims return to MDL 2738 and state courts. J&J faces resumed bellwether trial scheduling and renewed trial pressure. Bilateral settlement negotiations outside bankruptcy become the primary resolution mechanism.
Outcome 3: Negotiated Global Settlement (Non-Bankruptcy)
J&J and plaintiffs' leadership reach a voluntary global settlement agreement without bankruptcy court involvement, funded at a higher aggregate amount than the current plan, with distributions managed by a court-appointed administrator.
*Attorneys handling these claims note that Outcome 3, a negotiated non-bankruptcy global resolution, has precedent in mass tort history and may produce higher average per-claimant payments than the current bankruptcy plan.*
Looking at the timeline realistically:
| Milestone | Projected Date |
|---|---|
| Bankruptcy confirmation decision | Mid to late 2026 |
| Opt-out claims trial scheduling (if plan confirmed) | Late 2026 to 2027 |
| First distributions (if plan confirmed) | 2027 at earliest |
| Resumed MDL bellwether trials (if plan rejected) | 2026 to 2027 |
Bold Callout: If J&J's bankruptcy plan is rejected for a third time, legal analysts anticipate that J&J will face a wave of individual trials, potentially beginning in late 2026 or early 2027, with no further viable bankruptcy shield available.
Frequently Asked Questions
What is the current status of the Johnson & Johnson talcum powder lawsuit in 2026?
As of 2026, the litigation is active on two primary tracks: a bankruptcy confirmation proceeding before the U.S. Bankruptcy Court for the Southern District of Texas, reviewing J&J subsidiary Red River Talc LLC's $6.475 billion settlement plan, and live MDL activity before Judge Michael A. Shipp in New Jersey.
Approximately 62,000 federal claims are pending.
A decision on the bankruptcy plan is expected in mid to late 2026.
Who qualifies to file a claim in the J&J talcum powder lawsuit?
Women diagnosed with epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, or peritoneal mesothelioma after regular, long-term genital use of Johnson's Baby Powder or Shower to Shower are the primary qualifying group.
Family members of deceased claimants may file wrongful death or survival action claims.
Duration and frequency of product use, along with cancer stage and type, are central factors in claim valuation.
How much money can talcum powder lawsuit claimants receive in 2026?
Under the proposed bankruptcy plan, estimated per-claimant payments range from approximately $50,000 to $500,000 depending on cancer severity and case factors, before attorney fees.
Historical individual jury verdicts have ranged from $500,000 to over $2 billion for multi-plaintiff cases.
Claimants who opt out of the bankruptcy plan and proceed to trial may seek higher individual verdicts but face greater uncertainty and longer timelines.
Did Johnson & Johnson's bankruptcy strategy succeed in blocking talcum powder claims?
J&J's first two bankruptcy strategies, through LTL Management LLC, were rejected by the Third Circuit Court of Appeals and a New Jersey bankruptcy court in 2023.
The third attempt, through Red River Talc LLC filed in September 2024, is pending confirmation as of 2026.
No final global resolution has been achieved, and individual litigation rights remain intact for claimants who oppose the current plan.
What cancers are covered by the J&J talcum powder lawsuit?
The primary covered cancers are epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and peritoneal mesothelioma.
Ovarian cancer claims form the majority of the approximately 62,000 active claims in MDL 2738.
Mesothelioma claims follow a distinct asbestos-contamination causation theory and face disputed coverage under the current bankruptcy settlement plan.
Is it too late to file a talcum powder lawsuit claim in 2026?
Whether a claimant can still file depends on the state's statute of limitations and whether the discovery rule or fraudulent concealment tolling applies.
Most states allow two to five years from the date a claimant knew or should have known that their cancer was linked to talc use.
Claimants who believe they may have missed their deadline should consult a mass tort attorney, as tolling arguments based on J&J's concealment of internal asbestos testing data remain viable in multiple states.
Closing
The Johnson & Johnson talcum powder lawsuit is not a closed case. It is a live litigation with approximately 62,000 federal claims, ongoing bankruptcy confirmation proceedings, and active state court dockets in New Jersey, Missouri, and California. The outcome of the Red River Talc LLC bankruptcy confirmation in 2026 will define whether claimants receive structured plan payments or return to individual trial tracks.
For anyone who used Johnson's Baby Powder or Shower to Shower for years and has since been diagnosed with ovarian cancer or mesothelioma, the time to act is now, not after a plan is confirmed. A mass tort attorney who handles product liability and pharmaceutical litigation can assess your specific diagnosis, use history, and filing deadline at no upfront cost.
